4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-22-008029
Director bought 35,000 shares at $1.63 ($57,050)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Amin Dipti Director | 2022-03-28 | Purchase | +35,000 | $1.63 | $57,050 | 35,000 | D: show line 1 in the form |
| Open-market purchases · 35,000 sh · avg $1.63 · $57,050 | |||||||
Loading xslF345X03/ownership.xml…